positive cases and HLAtyping is only supportive (3). Hypocretin 1 and 2 (orexin A and B) are newly discovered neuropeptides, which were found by two isolated research groups in 1998 (4, 5). Hypocretin-containing neurons exist exclusively in the lateral hypothalamus and project widely to various monoaminergic cell groups in the brain (6). They are considered to be key neuropeptides controlling sleep and arousal states. One of the epochs of the clinical use of measuring the level of hypocretin 1 in cerebrospinal fluid was the finding of an extremely low level in narcolepsy patients and the usefulness of the diagnosis (7, 8) . The following reports confirmed the reliability of the measurement of hypocretin level in cerebrospinal fluid in narcolepsy (9-1 1). See also p 743.
Hypocretin 1 has also played an important role in energy homeostasis (9) and cardiovascular controlling system (14). The symptoms induced by hypothalamic lesion has been difficult to perceive due to the shortage of confirming methods if the symptomsare really derived from the lesion. Hypocretin 1 is a good marker which indicates the dysregulation or destruction of hypothalamic sleep and awakening system. If it is questionable whether the symptomscomefrom the hypothalamic lesion or not, the measurementof cerebrospinal hypocretin 1 can provide some information. It also suggests the determination if the symptomis hypersomnia or consciousness disturbance due to the cerebrovascular damage of bilateral hypothalamus in the case of infarction at the top of basilar artery. Further studies using these peculiar neuropepides are expected in various clinical fields.
Masanari Kunimoto, MD 
